- Home
- VKTX vs GENI Comparison
VKTX vs GENI Comparison
Compare VKTX & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- GENI
- Stock Information
- Founded
- VKTX 2012
- GENI 2016
- Country
- VKTX United States
- GENI United Kingdom
- Employees
- VKTX N/A
- GENI N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- GENI Services-Misc. Amusement & Recreation
- Sector
- VKTX Health Care
- GENI Consumer Discretionary
- Exchange
- VKTX Nasdaq
- GENI Nasdaq
- Market Cap
- VKTX 3.8B
- GENI 3.0B
- IPO Year
- VKTX 2015
- GENI N/A
- Fundamental
- Price
- VKTX $35.22
- GENI $11.73
- Analyst Decision
- VKTX Strong Buy
- GENI Strong Buy
- Analyst Count
- VKTX 14
- GENI 17
- Target Price
- VKTX $87.00
- GENI $13.88
- AVG Volume (30 Days)
- VKTX 4.8M
- GENI 5.0M
- Earning Date
- VKTX 10-22-2025
- GENI 11-04-2025
- Dividend Yield
- VKTX N/A
- GENI N/A
- EPS Growth
- VKTX N/A
- GENI N/A
- EPS
- VKTX N/A
- GENI N/A
- Revenue
- VKTX N/A
- GENI $558,439,000.00
- Revenue This Year
- VKTX N/A
- GENI $28.54
- Revenue Next Year
- VKTX N/A
- GENI $17.14
- P/E Ratio
- VKTX N/A
- GENI N/A
- Revenue Growth
- VKTX N/A
- GENI 25.76
- 52 Week Low
- VKTX $18.92
- GENI $6.72
- 52 Week High
- VKTX $79.10
- GENI $13.73
- Technical
- Relative Strength Index (RSI)
- VKTX 60.22
- GENI 43.30
- Support Level
- VKTX $33.00
- GENI $11.67
- Resistance Level
- VKTX $36.11
- GENI $12.17
- Average True Range (ATR)
- VKTX 2.02
- GENI 0.40
- MACD
- VKTX 0.09
- GENI 0.02
- Stochastic Oscillator
- VKTX 73.40
- GENI 37.74
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.